#ASCOGU: Pfizer’s prostate cancer data leak shows promising results in early-stage study

Clinical trial results from a Phase 1 study by Pfizer leaked days before a late-breaking presentation scheduled for Thursday, showing that the drugmaker’s prostate cancer candidate cut the risk of disease progression by around half ...